SKI Market

A+| A| A-|

Indian Indices

Sensex

76,913.50 -582.86
( -0.75%)

Global Indices

Nasdaq

49,692.16 809.34
(1.66%)

Dow Jones

7,235.98 79.03
(1.10%)

Hang Seng

59,594.47 309.55
(0.52%)

Nikkei 225

10,371.76 158.65
(1.55%)

Forex

USD-INR

94.79 0.27
(0.29%)

EUR-INR

110.85 0.20
(0.18%)

GBP-INR

127.93 0.23
(0.18%)

JPY-INR

0.59 0.00
(-0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Corporate Results - Detailed News

EQUITY - MARKET SCREENER

Back

Dr Lal Pathlabs consolidated net profit declines 15.18% in the March 2026 quarter

30-Apr-26 16:58 Hrs IST

Net profit of Dr Lal Pathlabs declined 15.18% to Rs 131.30 crore in the quarter ended March 2026 as against Rs 154.80 crore during the previous quarter ended March 2025. Sales rose 16.61% to Rs 702.70 crore in the quarter ended March 2026 as against Rs 602.60 crore during the previous quarter ended March 2025.

For the full year,net profit rose 3.63% to Rs 504.80 crore in the year ended March 2026 as against Rs 487.10 crore during the previous year ended March 2025. Sales rose 12.25% to Rs 2762.90 crore in the year ended March 2026 as against Rs 2461.40 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	702.70	602.60	17	2762.90	2461.40	12
OPM %	26.58	28.05	-	28.32	28.26	-
PBDT	204.70	189.80	8	861.00	766.60	12
PBT	160.10	153.40	4	699.20	624.70	12
NP	131.30	154.80	-15	504.80	487.10	4

76,913.50 -582.86 ( -0.75%)

49,692.16 809.34 (1.66%)

7,235.98 79.03 (1.10%)

59,594.47 309.55 (0.52%)

10,371.76 158.65 (1.55%)

94.79 0.27 (0.29%)

110.85 0.20 (0.18%)

127.93 0.23 (0.18%)

0.59 0.00 (-0.01%)